Crossmark

Development of a micro-tissue-mediated injectable bone tissue engineering strategy for large segmental bone defect treatment

Crossref DOI link: https://doi.org/10.1186/s13287-018-1064-1

Published Online: 2018-11-28

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Dingyu

Wang, Zhenxing

Wang, Jinbing

Geng, Yingnan

Zhang, Zhanzhao

Li, Yu

Li, Qiannan

Zheng, Zhiwei

Cao, Yilin

Zhang, Zhi-Yong https://orcid.org/0000-0003-3479-6513
Funding

Funding for this research was provided by:

National Key R&D Program of China (2016YFC1100100)

National Natural Science Foundation of China (81772354, 81572137, 81371964)

National Young Thousand-Talent Scheme
License Information

Text and Data Mining valid from 2018-11-28
More Information

Article History

Received: 31 July 2018

Revised: 18 October 2018

Accepted: 31 October 2018

First Online: 28 November 2018

Ethics approval and consent to participate

: The project complied with the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.